DRG Epidemiology’s coverage of celiac disease comprises epidemiological estimates of key patient populations across the mature markets (the United States, France, Germany, Italy, Spain and the United Kingdom). We report the total prevalence of celiac disease for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.
DRG Epidemiology’s celiac disease forecast will answer the following questions:
In the general population, how many in each country are living with celiac disease
Of all people with celiac disease, how many in each country have been formally diagnosed?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.
Total Prevalence of Celiac Disease per 100 Among People of All Ages in 2020 and 2040ttttttttt
Relative Sizes of the Factors Contributing to the Trend in Total Prevalent Cases of Celiac Disease over the Next Twenty Yearsttttttttt
Analysis of the Total Prevalent Cases of Celiac Disease in 2020 by Diagnosis Statusttttttttt
Number of Additional Total Prevalent Cases of Celiac Disease in 2040 Across the Countries Under Study Due to Trends in Risk or Survivalttttttttttttttttt
Epidemiology Data
Methods
Total Prevalence
Percentage Diagnosed
Reference Materials
Literature Review
Studies Included in the Analysis of Celiac Disease
Studies Excluded from the Analysis of Celiac Disease
Risk/Protective Factors
Bibliography
Abey John, M.P.H.
Abey John, M.P.H., is an epidemiologist at DRG, part of Clarivate. Prior to joining DRG, he worked with Jhpiego (an affiliate of Johns Hopkins Medical University) in implementing family planning health programs in India in collaboration with the government of India. He also has worked at the grassroots level as a health team manager to help the rural population living in the foothills of the Himalayas. He holds a master’s degree in public health.
Sunali D. Goonesekera, S.M.
Sunali Goonesekera, S.M., is a senior epidemiologist at Clarivate. Previously, Ms. Goonesekera conducted epidemiological research on racial/ethnic disparities in metabolic diseases at the New England Research Institute and lead-authored two manuscripts. She has contributed to multiple publications in peer-reviewed journals in epidemiology and the biological sciences. She holds a master’s degree in epidemiology from the Harvard School of Public Health and a B.A. in biology (Honors) from Dartmouth College.
